首页> 外文学位 >Genetic mechanism of autosomal dominant polycystic liver disease (ADPLD).
【24h】

Genetic mechanism of autosomal dominant polycystic liver disease (ADPLD).

机译:常染色体显性遗传性多囊性肝病(ADPLD)的遗传机制。

获取原文
获取原文并翻译 | 示例

摘要

Mutations in Prkcsh and Sec63, which are involved in protein translocation, folding and quality control pathways in the ER, have been shown to be associated with the occurrence of autosomal dominant polycystic liver disease (ADPLD). ADPLD is characterized by the presence of multiple bile duct-derived cysts. Prkcsh encodes the non-catalytic beta subunit of glucosidase II (GIIbeta), the ER glucose trimming enzyme involved in the calnexin-calreticulin cycle of integral membrane and secreted protein maturation and folding, whereas Sec63 codes for SEC63, which is associated with the Sec61/62 ER translocon. Since these two proteins are not directly linked with the primary cilia which has a well established role in the pathogenesis of polycystic disease, we first set forth to characterize the genetic interaction between the three main ciliary integral membrane cystic protein candidates, polycystin-1 (PC1), polycystin-2 (PC2), and fibrocystin/polyductin (FPC) and either Prkcsh or Sec63 using relevant mouse models. We found polycystin-1 to be the main regulator of the kidney and liver cystic phenotype due to inactivation of either Prkcsh or Sec63 as heterozygosity or overexpression at the Pkd1 locus worsened or rescued the cystic phenotype, respectively. We have also revealed a novel interaction between one of the ADPLD loci ( Sec63) and ARPKD (Pkhd1) as the double mutant mice display a much more severe phenotype than either of the single mutants which implies that Sec63 may be a modulator of both the ADPKD and ARPKD phenotypes in patients.;At the molecular level, we found a correlation between Pkd1 dosage and a pro-proliferative response on both the Prkcsh and Sec63 loss-of-function background. Furthermore, the expression and trafficking of polycystin-1 was reduced in the absence of Prkcsh , further supporting the genetic findings.;Finally we have unveiled a biochemical and genetic interaction between the Ire1-Xbp1 branch of the unfolded protein response (the main transcriptional modulator of UPR) and Sec63 , where the Sec63/Xbp1 knockout animals displayed an exacerbation of the phenotype compared with Sec63 mutants alone suggesting the UPR is playing a protective role in the absence of Sec63.;In conclusion, our findings lend support to the idea of a non-allelic complementation network present among ADPLD-ADPKD-ARPKD-UPR genes.
机译:Prkcsh和Sec63中的突变与ER中的蛋白质易位,折叠和质量控制途径有关,已显示与常染色体显性多囊性肝病(ADPLD)的发生有关。 ADPLD的特征是存在多个胆管衍生的囊肿。 Prkcsh编码葡糖苷酶II(GIIbeta)的非催化β亚基,后者是参与整合膜钙连蛋白-钙网蛋白循环以及分泌的蛋白质成熟和折叠的ER葡萄糖修剪酶,而Sec63则编码SEC63,与Sec61 / 62 ER转运子。由于这两种蛋白并不直接与在多囊性疾病的发病机理中具有公认作用的原发纤毛直接相连,因此我们首先着手表征三种主要的睫状完整膜囊性蛋白候选物多囊蛋白-1(PC1 ),polycystin-2(PC2)和fibrocystin / polyductin(FPC)以及使用相关小鼠模型的Prkcsh或Sec63。我们发现,由于Prkcsh或Sec63的失活(由于杂合性或Pkd1基因座处过表达或过表达使Pkd1位点恶化或挽救了),多囊藻蛋白1是肾脏和肝囊性表型的主要调节因子。我们还揭示了ADPLD位点(Sec63)和ARPKD(Pkhd1)之间的新型相互作用,因为双突变小鼠的表型比单个突变体中的任一个都严重得多,这暗示Sec63可能是两个ADPKD的调节剂在分子水平上,我们发现Pkd1剂量与Prkcsh和Sec63功能丧失背景下的增殖反应之间存在相关性。此外,在没有Prkcsh的情况下,polycystin-1的表达和运输减少了,进一步支持了遗传学发现。最后,我们揭示了未折叠蛋白应答的Ire1-Xbp1分支之间的生化和遗传相互作用(主要的转录调节因子(UPR)和Sec63(其中Sec63 / Xbp1基因敲除动物与单独的Sec63突变体相比表现出了表型的恶化),表明UPR在缺乏Sec63的情况下起保护作用。总之,我们的发现为以下观点提供了支持: ADPLD-ADPKD-ARPKD-UPR基因之间存在的非等位基因互补网络。

著录项

  • 作者

    Fedeles, Sorin Vasile.;

  • 作者单位

    Yale University.;

  • 授予单位 Yale University.;
  • 学科 Biology Genetics.;Biology Cell.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 211 p.
  • 总页数 211
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号